Bristol-Myers Squibb
BMY
BMY
2,456 hedge funds and large institutions have $91.5B invested in Bristol-Myers Squibb in 2024 Q4 according to their latest regulatory filings, with 365 funds opening new positions, 921 increasing their positions, 905 reducing their positions, and 107 closing their positions.
Holders
2,456
Holders Change
+220
Holders Change %
+9.84%
% of All Funds
32.71%
Holding in Top 10
39
Holding in Top 10 Change
+13
Holding in Top 10 Change %
+50%
% of All Funds
0.52%
New
365
Increased
921
Reduced
905
Closed
107
Calls
$1.75B
Puts
$1.75B
Net Calls
+$7.86M
Net Calls Change
+$118M
Top Buyers
| 1 |
1
Norges Bank
Oslo,
Norway
|
$1.99B |
| 2 |
2
JPMorgan Chase & Co
New York
|
$5.43B |
| 3 |
3
Ameriprise
Minneapolis,
Minnesota
|
$1.81B |
| 4 |
4
DZ Bank
Frankfurt Am Main,
Germany
|
$705M |
| 5 |
5
Wellington Management Group
Boston,
Massachusetts
|
$338M |
Top Sellers
| 1 |
1
Fidelity Investments
Boston,
Massachusetts
|
$1.76B |
| 2 |
2
T. Rowe Price Associates
Baltimore,
Maryland
|
$426M |
| 3 |
3
Two Sigma Advisers
New York
|
$105M |
| 4 |
4
Two Sigma Investments
New York
|
$4.84M |
| 5 |
5
Amundi
Paris,
France
|
$292M |
